STAT3 and non-small cell lung carcinoma: In a panel of NSCLC cell lines, we found that STAT3 is involved downstream in the transcriptional regulation of PD-L1 caused by RAS/MEK, thus providing another mechanistic rationale to combine MEK-I and anti-PD-L1 inhibitors.